Monterey Bio Acquisition Corp MTRY
We take great care to ensure that the data presented and summarized in this overview for Monterey Bio Acquisition Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MTRY
Top Purchases
Top Sells
About MTRY
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.
Insider Transactions at MTRY
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 09
2023
|
Chardan Monterey Investments LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
478,125
+30.25%
|
$0
$0.01 P/Share
|
Mar 09
2023
|
Chardan Monterey Investments LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
13,125
-2.06%
|
$0
$0.01 P/Share
|
Mar 09
2023
|
Jonas Grossman Director |
BUY
Open market or private purchase
|
Indirect |
478,125
+30.25%
|
$0
$0.01 P/Share
|
Mar 09
2023
|
Jonas Grossman Director |
SELL
Open market or private sale
|
Indirect |
13,125
-2.06%
|
$0
$0.01 P/Share
|
Mar 09
2023
|
Sanjeev Satyal |
SELL
Other acquisition or disposition
|
Direct |
75,000
-50.0%
|
-
|
Mar 09
2023
|
Northstar Bio Ventures, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
75,000
+5.03%
|
-
|
Mar 09
2023
|
Northstar Bio Ventures, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
570,000
-29.8%
|
$0
$0.01 P/Share
|
Mar 09
2023
|
Sandip I Patel Director |
BUY
Other acquisition or disposition
|
Indirect |
75,000
+5.03%
|
-
|
Mar 09
2023
|
Sandip I Patel Director |
SELL
Open market or private sale
|
Indirect |
570,000
-29.8%
|
$0
$0.01 P/Share
|